Ozempic may soon be hard to find in Canada as supplier cites shortage

A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer said Friday.

Novo Nordisk said it is experiencing a temporary supply disruption with the Ozempic its one-millagram injection pen.

It said the shortage is due to a combination of global supply constraints and increased demand for the drug.

Health Canada said intermittent shortages are expected from late August to early October.

Both Health Canada and Novo Nordisk say the 0.25 mg and 0.5 mg doses of Ozempic remain available for patients with Type 2 diabetes.

They say pharmacists are encouraged to limit refill prescriptions to a 30-day supply.

More to come


More on Canada

&copy 2023 The Canadian Press


Articles You May Like

Army Veteran Stands in Check Out Line at Grocery Store – Suddenly, a Stranger Utters 10 Words That Leaves Him Stunned
[Free Event] Collective Trauma Summit: Creating a Global Healing Movement
How I Stopped Feeling Like There Was Something Wrong with Me
Ads are coming to Amazon Prime Video — or you can escape them for a fee
9-Year-Old Bullies Classmate With Hurtful Words – But He Responds by Issuing Him an Unexpected Invitation

Leave a Reply

Your email address will not be published. Required fields are marked *